2021 marks 50 years since the National Cancer Act was signed into law. Since then, enormous progress has been made in oncology – from dramatically reduced mortality rates from cancer to the invention of targeted, personalized therapies, and wider access to experimental treatment through clinical trials. We’ll assess how far we’ve come in 50 years and how much further we can go in the next 50. Join U.S. health officials and advocates on Thursday, June 17 for a conversation half a century in the making.
Stream here: wapo.st/chasingcancerjune2021
Â
Content from AstraZeneca
One Oncology Community: The Future of Cancer Care Amid the Pandemic and Beyond
This year marks 50 years since the National Cancer Act was signed into law by President Nixon. Since then, extraordinary strides have been made in oncology science and care, evidenced by steady declines in cancer mortality to the advent of screening programs and targeted therapies that have redefined care for millions. As we look at the advancements made over the past 50 years, this segment will focus in on precision medicine, examining its role amid the COVID-19 pandemic and beyond with an emphasis on improving patient outcomes.